← Back to Clinical Trials
RecruitingPhase 3NCT03925662
Mebendazole as Adjuvant Treatment for Colon Cancer
Trial Parameters
ConditionColorectal Cancer
SponsorSherief Abd-Elsalam
Study TypeINTERVENTIONAL
PhasePhase 3
Enrollment40
SexALL
Min Age18 Years
Max AgeN/A
Start Date2019-04-01
Completion2028-12
Interventions
Folfox with avastinMebendazole
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
mebendazole treating colon cancer
Eligibility Criteria
Inclusion Criteria: * Colorectal cancer stage 4. Exclusion Criteria: * Agranulocytosis * Pregnancy * Allergy to mebendazole.